News

The data is being presented at the European Organisation for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force Meeting in London, United Kingdom, by Christiane Querfeld,

Nivolumab works by binding to certain proteins in cells. This then stimulates the body’s immune system to attack cancerous cells and destroy them. When NICE first reviewed nivolumab,

All the ten members of the FDA’s Dermatologic and Ophthalmic Drugs Advisory Committee voted in favor of netarsudil ophthalmic solution, which is intended to be used daily once.

"We've seen promising evidence that WP1066 has potent anticancer effects in animal tumor models due to its unique mode of action," commented Walter Klemp, Chairman and CEO of

Characterized by the World Health Organization as a "neglected tropical disease," leprosy (also known as Hansen's disease) is one of the most ancient diseases known to humankind and

The investigational adeno-associated viral (AAV) vector gene therapy was unanimously approved by all the 16 members of the Cellular, Tissue and Gene Therapies Advisory Committee of the drug

The study hit statistical significance for the primary endpoint and all secondary endpoints evaluated for the topline results and demonstrated the ability to normalize bowel movements. The primary

Currently, there are no FDA approved treatments for patients with non-metastatic CRPC. This submission is based on Phase 3 data from the pivotal ARN-509-003 (SPARTAN) clinical trial, which

Founded in 2012, Symbiomix Therapeutics, which is based in Newark, New Jersey, is focused on developing therapies for gynecologic infections that can have serious health implications. Through its